Clinical outcome in patients treated with simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal.

Conclusions SIB-IMRT ± concurrent chemotherapy for anal cancer was effective with acceptable toxicity. PMID: 26878244 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26878244?dopt=Abstract

Source: Acta Oncologica - February 15, 2016 Category: Cancer & Oncology Authors: Tomasoa NB, Meulendijks D, Nijkamp J, Cats A, Dewit L Tags: Acta Oncol Source Type: research